首页> 外文期刊>Modern Pathology >Immunohistochemistry on Cell Blocks From Fine-Needle Cytopunctures of Primary Breast Carcinomas and Lymph Node Metastases
【24h】

Immunohistochemistry on Cell Blocks From Fine-Needle Cytopunctures of Primary Breast Carcinomas and Lymph Node Metastases

机译:免疫组织化学对原发性乳腺癌细针细胞穿刺和淋巴结转移的细胞阻滞作用

获取原文
       

摘要

We assessed the reliability of prognostic biologic markers by means of immunohistochemistry on cell blocks obtained from diagnostic fine-needle cytopunctures of breast carcinomas and their lymph node metastases.Immunohistochemical studies of MIB-1 (Ki-67), estrogen receptors (ER), progesterone receptors (PR), p53, and c-erb-B-2 were performed in 55 cases of primary breast carcinoma on cell blocks (cytoblock technique) and on their corresponding tissue samples (46 mastectomy specimens and 9 Trucut biopsies) and in 38 cases on cell blocks from fine-needle cytopunctures of both the primary breast tumors and their concurrent lymph node metastases.Interobserver reproducibility ranged from 87 to 100%, depending on the marker. A good correlation was observed between immunostaining assessment on cell blocks and on the corresponding tumor tissues as follows: Ki-67 (85%), ER (96%), PR (82%), p53 (76%), and c-erb-B-2 (84%). An excellent correlation was observed between cell-block results for primary tumors and node metastases; however, a far higher percentage of Ki-67–positive nuclei was observed in the nodes than in the corresponding tumors in seven cases. All nodes corresponding to ER- or PR-negative tumors were also negative, whereas the nodes corresponding to two ER-positive and one PR-positive tumor were negative. Marked discrepancies were also noted with p53 in two cases and with c-erb-B-2 in two cases. Most discrepancies occurred with Trucut biopsies and with breast tumors that contained a large intraductal component.We conclude that cell blocks prepared from fine-needle cytopuncture specimens of breast carcinomas and their node metastases are useful when planning neoadjuvant treatment.
机译:我们通过免疫组织化学方法对乳腺癌及其淋巴结转移的诊断性细针细胞穿刺获得的细胞块进行免疫组化评估,评估了预后生物学标志物的可靠性.MIB-1(Ki-67),雌激素受体(ER),孕酮的免疫组织化学研究在55例原发性乳腺癌的细胞块(细胞块技术)及其相应的组织样本(46例乳房切除术标本和9例Trucut活检样本)中对38例患者进行了受体(PR),p53和c-erb-B-2的检测细针细胞穿刺对原发性乳腺肿瘤及其并发淋巴结转移的细胞阻滞作用。观察者间的可重复性范围在87%至100%之间,具体取决于标记物。在细胞块和相应肿瘤组织的免疫染色评估之间观察到良好的相关性,如下:Ki-67(85%),ER(96%),PR(82%),p53(76%),和c-erb-B-2(84%)。在原发性肿瘤的细胞阻滞结果与淋巴结转移之间观察到极好的相关性;然而,在7例中,在淋巴结中观察到的Ki-67阳性核百分比远高于相应的肿瘤。与ER或PR阴性肿瘤相对应的所有淋巴结均为阴性,而与2例ER阳性和1例PR阳性肿瘤相对应的淋巴结均为阴性。在两个案例中还发现p53和c-erb-B-2有明显的差异。大多数差异发生在Trucut活检和包含大的导管内成分的乳腺肿瘤中。我们得出结论,从乳腺细针细胞穿刺标本制备的细胞块及其淋巴结转移对于计划新辅助治疗很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号